spacer
home > pmps > winter 2001 > wip versus cip - the pros and cons of two cleaning philosophies
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

WiP Versus CiP - The Pros and Cons of Two Cleaning Philosophies

WiP or CiP? Clean or pure? Only the user can decide which system best suits their needs. A comparison of the two cleaning philosophies reveals that it is possible to exploit the advantages of the WiP method without sacrificing either cleanliness or safety.

In principle, however, washing the compression compartment of tablet presses represents a significant increase in the level of automation when changing products. This is particularly true where hazardous or extremely dusty granulates are being pressed. Difficulties created in the working area are significantly reduced, and the materials handling process is greatly simplified.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Jörg Petersen and Hans-Joachim Pierags of Wilhelm Fette GmbH, Germany
spacer
Jörg Petersen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Qatar Airways Resumes Scheduled Belly-hold Cargo Operations to China in Response to Increased Demand

Qatar Airways becomes the first Middle Eastern carrier to resume belly-hold operations to all of its destinations in China by leveraging the flexibility and reliability of its modern fleet of 250 aircraft. Belly-hold cargo service to Beijing resumed on 30 March, services to Shanghai, Hangzhou and Chengdu will resume on 31 March and Guangzhou and Chongqing will resume on 01 April.
More info >>

White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement